ARCHIVES

Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

Some NCI Advisors Tell GAO Congress “Jumped The Gun” In Creating Cancer Control Program

October 26, 1979

NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept

May 22, 1981

Broad Institute wins NIH grant for first national SNP genotyping center.

October 8, 2004

NIOSH To Fund 21 Projects With NCI Money

February 25, 1977

SEC Notifies ImClone It May Bring Action Against Company

June 21, 2002

Other News: ESAs Fail To Reduce Blood Transfusions, SEER Data Show

November 20, 2009